DIABETES MELLITUS PART 2 Flashcards
sudden onset polyuria 25% present with DKA weight loss blurred vision paresthesias
type I DM
gradual onset of hyperglycemia
metabolic signs often realized in retrospect
GU signs: balanitis, candidly vulvovaginitis
type 2 DM
what percent of dosing should be basal insulin?
40-50%
NPH, Detemir, Glargine are examples of what kind of insulin?
what about Degludec?
basal insulin, intermediate to long acting preparation
basal insulin, very long acting
this is the preferred initial agent in asymptomatic patients without catabolism
if A1C is greater 7.5-8% then medication should be considered?
side effects: GI, Vit B12 deficiency, reduced lactate uptake by liver
metformin
what conditions should you worry about lactic acidosis with the use of metformin?
renal failure
liver failure
excess alcohol intake
all the above
all the above
the goal Hgb A1C for most patients being for treated diabetes is?
<6 <6.5 <7 <7.5 <8
goal Hgb A1C <7.0%
FBG 80-130 mg/dL PP glucose (90-120 min) <180 mg/dL
of the parameters listed, which is least important in the CV health of an elderly patient?
cholesterol
blood pressure
fasting blood sugar
blood sugar
when considering secondary medication following metformin in a diabetic patient with continued elevation of Hgb A1C level and established CV disease, which agent is preferred?
GLP-1 RA
Glyburide
SGLT-2 inhibitor
insulin
GLP-1 RA
reduces incidence of:
nonfatal MI
nonfatal stroke
death from CV causes
and
slow the rate of decline in GFR and worsening of albuminuria
when considering secondary medication following metformin in a diabetic patient with continued elevation of Hgb A1C level and heart failure, which agent is preferred?
GLP-1RA
Glyburide
SGLT-2 inhibitor
insulin
SGLT-2 inhibitor
empagliflozin and canagliflozin lower CV death (MI, stroke)
dapagliflozin lowers risk of HF or CV death
if HF or CKD, SGLT2 inhibitors slow the rate of decline of GFR
common side effect of SGLT-2 inhibitors is?
thrombocytopenia
GU yeast infections
Rash
anaphylaxis
GU yeast infections
when considering secondary medication following metformin in a diabetic patient with fasting BG?250 mg/dL, Hgb A1C level >9.0% and ketonuria, which agent is preferred?
GLP-1RA
glyburide
SGLT-2 inhibitor
insulin
insulin
which meds for diabetes can causes weight gain?
insulin and sulfonylureas
GLP-1 RAs and DPP-4 inhibitors
SGLT-2 inhibitors
metformin
insulin and sulfonylureas
of the medications listed below, which is considered first line for tx for HFrEF?
empagliflozin
sacubitril/valsartan
lisinopril
epleronone
sacubitril/valsartan
what SGLT-2 inhibitor has been added to the list of recommended agents in HFrEF?
empagliflozin